![]() |
|
|
Vol. 300, Issue 3, 992-999, March 2002
-Receptor Based on
The Structure of the Orphanin FQ Receptor
Mental Health Research Institute, Department of Psychiatry, School
of Medicine, University of Michigan, Ann Arbor, Michigan
It is unclear how opioid selectivity and activation are regulated
within the receptor core. In previous studies, the OFQ receptor was
converted into a functional opioid receptor by mutating five amino
acids at three sites to the corresponding residues conserved across the
µ-,
-, and
-opioid receptors, suggesting that these sites
comprise an opioid binding pocket. To examine this hypothesis, the
present study examines whether these conserved residues represent an
opioid binding pocket in the context of the opioid receptors, i.e.,
does their removal from opioid receptors destroy opioid ligand binding?
The reciprocal mutations K227A (transmembrane [TM]5), IHI290-292VQV
(TM6), and I316T (TM7) were evaluated in the
-opioid receptor. In
terms of alkaloid binding, there were no changes in affinity for
mutants K227A and IHI290-292VQV. At mutant I316T, antagonist binding
was unaltered, but there was a trend toward slightly decreased agonist
affinity. In contrast, the binding of peptides had a more complex
pattern. Again, K227A and IHI290-292VQV did not decrease the binding
affinity of dynorphin-related peptides. Mutant I316T had 10- to 20-fold
decreased affinity for dynorphin-related peptides, suggesting that
I316 is part of a critical dynorphin recognition site. In
response to alkaloid stimulation, I316T activated more G-protein(s)
than wild type, and similar levels were observed in response to
dynorphin stimulation. Overall, these results suggest that ligands are
capable of achieving high-affinity binding through interaction with
multiple sites/conformations of the receptor. These different modes of interaction have different down-stream results in terms of receptor activation and signal transduction.
This article has been cited by other articles:
![]() |
C S. Bradford, E. A Walthers, B. T Searcy, and F. L Moore Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa J. Mol. Endocrinol., June 1, 2005; 34(3): 809 - 823. [Abstract] [Full Text] [PDF] |
||||